Fibrinogen

SHBG (Sex Hormone Binding Globulin)

eGFR (Estimated Glomerular Filtration Rate)

TNF-α (Tumor Necrosis Factor-alpha)

Bicarbonate

ANA (Antinuclear Antibody)

RDW (Red Cell Distribution Width)

TIBC (Total Iron Binding Capacity)

Total Cholesterol

Homocysteine

Apolipoprotein A1

Alkaline Phosphatase (ALP)

LDL Particle Number

Phosphorous

25(OH)D (25-Hydroxyvitamin D)

GGT (Gamma-Glutamyl Transferase)

Hemoglobin A1C

Lymphocytes (Absolute)

BUN (Blood Urea Nitrogen)

Serum Iron

Fasting Insulin

RBC (Red Blood Cell Count)

Uric Acid

Albumin

IGF-1 (Insulin-Like Growth Factor 1)

NRBC (Nucleated Red Blood Cells)

EPA (Eicosapentaenoic Acid)

Neutrophils (Absolute)

LDH (Lactate Dehydrogenase)

Chloride

DHEA-S (Dehydroepiandrosterone Sulfate)

Calcium

Free Testosterone

HDL Cholesterol

IL-6 (Interleukin-6)

Tg Ab (Thyroglobulin Antibodies)

Cystatin C

A/G Ratio (Albumin/Globulin Ratio)

RBC Magnesium

Free T3 (Triiodothyronine)

ALP is a biomarker commonly used for assessing longevity. Maintaining optimal levels of this enzyme can be a key indicator of overall health and longevity.

Alkaline Phosphatase (ALP)

Alkaline Phosphatase (ALP) is a biomarker that is often used in longevity studies to assess overall health and potential lifespan. ALP levels in the blood can indicate liver or bone health, as well as other metabolic processes. High ALP levels may suggest underlying liver disease or bone disorders, while low levels can be associated with malnutrition or certain genetic conditions. Monitoring ALP as part of a comprehensive biomarker panel can provide valuable insights into an individual’s overall health and potential longevity, helping to identify areas for intervention and personalized health optimization strategies.

Biomarker Explained

Alkaline Phosphatase (ALP) is a crucial biomarker utilized in longevity studies to evaluate an individual’s overall health and potential lifespan. ALP levels in the blood can yield valuable information regarding liver and bone health, as well as other metabolic processes. Elevated ALP levels may indicate underlying liver disease or bone disorders, necessitating further investigation and potential intervention. On the other hand, low ALP levels can be associated with malnutrition or certain genetic conditions, highlighting the need for personalized health optimization strategies. Monitoring ALP as part of a comprehensive biomarker panel can offer insightful data on an individual’s overall health and potential longevity, enabling the identification of areas for intervention and the development of personalized health strategies. This underscores the importance of incorporating ALP into longevity studies and personalized health plans to maximize overall well-being and longevity potential.

Keywords:

Alkaline Phosphatase, ALP, Biomarker, Longevity, Liver health, Bone health, Personalized health strategies

Complete Patient Intake Form

Continue Browsing Our Offers